Lynwood Capital Management Inc. Bio Cardia, Inc. Transaction History

Lynwood Capital Management Inc.

  • $11.2 Million
  • Q1 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.52 - $2.8 $195,964 - $360,987
128,924 New
128,924 $344,000

About BioCardia, Inc.

BCDA Quotes by TradingView
  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $41.2M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Lynwood Capital Management Inc. Portfolio

Follow Lynwood Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynwood Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lynwood Capital Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email